Ascension Orthopedics Introduces the Silicone PIP Implant System
AUSTIN, Texas, Feb. 13 /PRNewswire/ -- Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the release of the Ascension(R) Silicone
PIP System at the American Academy of Orthopaedic Surgeons. This system features the smallest pre-flexed silicone proximal interphalange...
Coalition to Protect Florida's Drivers Applauds Governor Crist for Adding PIP to Special Session
TALLAHASSEE, Fla., Oct. 1 /PRNewswire-USNewswire/ -- The Coalition to
Protect Florida's Drivers praised Governor Charlie Crist today for his
leadership and thanked him for expanding the call of this week's special
session to include no-fault auto insurance. No-fault expired at midnight
today. ...
PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
...
ANNAPOLIS, Md., July 27 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that it has signed definitive agre...
Partners in Policymaking Graduates New Generation of Disability Leaders
...te a new class of Partners in Policymaking (PIP) on Saturday, May 16, 2009.
pip class participants, Partners, are a diverse group of highly motivated adult...wide range of backgrounds and abilities from all across Virginia.
The
pip Class of 2009 joins the ranks of over 325 Partners statewide with demonstra...
PharmAthene Reports Year End 2008 Financial Results
... ANNAPOLIS, Md., March 30, /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported operational and financial results f...
New IRC Study Documents Role of Chiropractors in Minnesota's No-Fault Auto Insurance System
...sed 30 percent, from $122 to $158
per visit. In addition, the percentage of
pip claimants receiving
chiropractor treatment increased approximately 5 percen...e of attorneys in the no-fault system
and found that 24 percent of all 2007
pip claimants in Minnesota were
represented by attorneys. Average claimed losse...
PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
...PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ --
PharmAthene, Inc. (Amex:
pip ), a biodefense company developing medical
countermeasures against biologic...ngineered strains of anthrax. About PharmAthene, Inc. PharmAthene (Amex:
pip ) was formed to meet the critical needs of the
United States and its allies...
PharmAthene to Present at the Rodman and Renshaw/Acumen BioFin 9th Annual Healthcare Conference
...pharmathene.com under the Investor Relations section, or at
http://www.wsw.com/webcast/rrshq12/pip .
About PharmAthene, Inc.
PharmAthene (AMEX:
pip ) was formed to meet the critical needs of the
United States and its Allies by developing and commercializing medical
countermeasures against biologic...
Hospital Coalition Says Governor's No-Fault Bill Signing Provides a 'Great Protection' for Florida Consumers
...treated
at hospital emergency rooms have no health insurance and, for many,
pip is
their only coverage. By extending no-fault and mandatory PIP, Governor
C...pital
Association and a Coalition leader. Additionally, the restoration of
pip means that Florida's fragile
trauma care network and emergency room physici...
Hospitals and the Coalition to Protect Florida's Drivers Applaud Lawmakers for Reviving No-Fault Insurance
...age 65 has no
health insurance and that, for many,
pip is their only source of medical
coverage, it is clear how critical
pip is for both patients and the
hospitals and trauma ...h drivers involved in an accident
have PIP. Though
pip is not mandatory until January, drivers still can
...
More>>
PIP in Medical Technology
PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
... ANNAPOLIS, Md., June 2 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that it has submitted a proposal t...
PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
... ANNAPOLIS, Md., May 22 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company has submitted its...
PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
... ANNAPOLIS, Md., April 28 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it will be hosting a conferenc...
Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
... ANNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ --PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that new mechanism of action data ...
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
... ANNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
(Amex:
pip ), a biodefense company developing medical countermeasures
against biological and chemical threats, announced today that the Company
is presenting two...
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
...ients with MP contractures and seven patients with
pip contractures
were enrolled in the study. No measur...nd and
the Proximal Intra-Phalangeal Joint, or the
pip joint, which is the middle
joint in the finger. Th...ts to < / = 5 degrees of normal. In CORD
I, MP and
pip patients were stratified in a 2:1 ratio.
All pat...
PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease
...LIS, Md., April 9, 2008 /PRNewswire-FirstCall/ -- PharmAthene,
Inc. (Amex:
pip ) a biodefense company specializing in the development and
commercializatio...hich are
exceedingly toxic.
About PharmAthene, Inc.
PharmAthene (Amex:
pip ) was formed to meet the critical needs of the
United States and its allies...
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
...s called the metacarpophalangeal joint, or MP
joint, which is the joint closest to the palm of the hand and the proximal
interphalangeal joint, or the
pip joint, which is the middle joint in the
finger. The little finger and ring finger are most frequently involved. (1) Badalamente, M. A., Hurst, L. C. ...
More>>
PIP in Medical Products
Bunnell Mini-Modified Safety Finger Pin
Description:... Bunell Mini-Modified Safety Finger Pin reduces
pip flexion contractures....
Company:AliMed, Inc.
Banana Split Splint
Description:... The Banana Split Splint reduces
pip joint or DIP joint flexioncontractures of any degree. Hinged design is easy to put on. Soft gel-lining cushions injured fingers so treatment to straig...
Company:3-Point Products
Finger Sled
Description:...ning and non-slip fit. FingerSled splints can be worn at night to lessen stress on fingers with Osteoarthritis, for correction following injury to the
pip joint or DIP joint of the fingers. Use after surgery to repair collateral ligament injuries. Each FingerSled Splint can be used to correct either medi...
Company:3-Point Products
FoamWrap™ Final Flexion Wrap
Description:... FoamWrap Final Flexion Wraps restore full
pip joint or DIP joint flexion following injury or when lost due to arthritic changes. Unparalleled in comfort and softness, the breathable, foam-lined ma...
Company:3-Point Products
HARMONY® Orthopedics
Description:...al records, demographic information, insurance reporting, medication monitoring, admission scheduling, radiology orders & reports, laboratory results,
pip and Comp. Patient Management....
Company:Medical Technology International
NeuFlex™ MCP/PIP Finger Joint Implant Systems
Description:... The design of the NeuFlex™ MCP and/or
pip Finger Joint Implant is based on numerous research studies of the structure and mechanics of the MCP/PIP joint. This prosthesis is inserted into metac...
Company:DePuy Orthopaedics, Inc.
The Avanta Soft Skeletal Hand Implant System
Features:... The Avanta MCP and
pip Soft Skeletal Implants constructed of Silflex II advanced elastomer, offer ...h accommodates the specific, unique biomechanics and anatomy of the MCP and
pip joints.
Each product has supporting instruments consisting of color cod...
Company:Small Bone Innovations, Inc.
EU-M60 Endoscopic Ultrasound Center
Features:...ear images at the same time
A sub-screen is available so you can view ultrasound images on the main screen and endoscopic images on the 2-position
pip format
Expanded imaging functionality allows greater and easier control over CONTRAST, GAIN STC, FREQUENCY, Gamma Curve, and post-processing opera...
Company:Olympus America Medical
More>>
PIP in Biological Technology
PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
...
ANNAPOLIS, Md., Aug. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...
PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
...
ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it ...
PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
... ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Admini...
PharmAthene Reports First Quarter 2009 Financial and Operational Results
...
ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...
PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
... ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 ...
PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...
PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
... ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase I...
PharmAthene Announces $5.5 Million Public Equity Offering
... ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:
pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that certain institutional investo...
PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
... ANNAPOLIS, Md., March 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex:
pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...
PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
...atric Investigation Plan (PIP) Advisory from PAREXEL Consulting, with an update and guidance on how biopharmaceutical companies should address the new
pip requirements, will be provided at PAREXEL's Booth #1522 . PAREXEL experts will also be available at the booth to hold exclusive executive briefings w...
More>>